September 14, 2022 Oxford Biomedica Solutions signs agreement with new partner for AAV platform OXFORD, UK: Oxford Biomedica plc (LSE:OXB), a leading gene and cell therapy group, today announced that its subsidiary Oxford Biomedica Solutions LLC (“Oxford Biomedica…